WHAT: The National Institutes of Health will host "Advances in Uterine Leiomyoma Research: 2nd NIH International Congress" on February 24 25. This conference will bring together researchers working in the fields of biomedicine, epidemiology, basic research, therapeutics, and translational medicine to foster an exchange of scientific information among members of the uterine leiomyoma (fibroids) research and health care communities. Fibroids are the most common gynecologic neoplasm in women of reproductive age and the leading cause of hysterectomy in the United States. Topics to be covered include Clinical Experiences and Therapeutic Strategies, Epidemiology, Clinical Trials, Pathogenesis of Smooth Muscle Tumors, and Molecular and Genetics Characteristics.
WHEN: February 24-25, 2005
WHERE: Natcher Conference Center, National Institutes of Health
Bethesda, MD 20892
WHO: This conference will be co-chaired by Dr. Vivian Pinn, Associate Director for Women's Health and Director, Office of Research on Women's Health (ORWH), NIH and Dr. Kenneth Olden, Director, National Institute of Environmental Health Sciences, NIH. Program co-chairs include Dr. J. Carl Barrett, National Cancer Institute (NCI), Drs. Estella Parrott and James Segars, National Institute of Child Health and Human Development (NICHD), and Dr. Barbara J. Davis, AstraZeneca. Participants will represent academia, medical centers, government, industry, and advocacy groups.
NOTE TO EDITORS:
This congress is a joint effort within the Department of Health and Human Services,
including the NIH ORWH, NIEHS, NICHD, NCI, National Institute of Biometry and Biomedical Sciences (NIBIB), National Center for Research Resources (NCRR), and the following DHHS entities: Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Health Research and Services Administration (HRS
'"/>
Contact: Vicki Malick, NIH Office of Research on Womens Health
301-402-1770
NIH/Office of the Director
17-Feb-2005
Page: 1 2 Related medicine news :1.
Advances in plasma physics at Annual APS Meeting2.
Advances in plasma physics at Annual APS Meeting3.
Advances in understanding brain circuits responsible for tics in Tourettes shed light on disorder4.
Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting5.
Advances emerging in hepatitis management6.
Advances in prevention and treatment research hold promise for pipeline7.
Advances in MRI imaging may lead to new standards for faster diagnosis of multiple sclerosis8.
Peanut Allergy: Major Advances in Treatment and Education9.
"Radical" Discovery Advances Medicine and Plastics10.
Advances in On the Spot tests have huge public health implications11.
Immunex Advances CD40 Ligand To Phase II Clinical Trial In People With Metastatic Kidney Cancer